ReviewDrug delivery and translational research2026
Ink to innovation: Pioneering printing technologies for next-generation drug delivery systems.
Review in Drug delivery and translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inkjet printing has emerged as a revolutionary technology in pharmaceutical manufacturing, offering unprecedented precision in the deposition of active pharmaceutical ingredients (APIs) and excipients. Its ability to accurately dispense nano- to picolitre volumes without direct contact with the substrate enables the development of complex and highly uniform dosage forms. This technology is uniquely positioned to overcome many limitations of conventional manufacturing processes, especially in the development of personalised and controlled-release formulations. In this review, we provide a comprehensive analysis of the principles, mechanisms, and advancements in inkjet printing technology for pharmaceutical applications. The review covers an overview of the fundamentals of inkjet printing, including drop-on-demand systems, thermal and piezoelectric printing modalities, and the critical parameters that govern droplet formation. We then examine its diverse applications, ranging from studying drugs in solid states to the production of novel formulations and personalised dosage forms. In addition, the integration of inkjet printing with advanced analytical tools is discussed, which has improved quality control and enabled high-throughput screening of drug formulations. Challenges related to ink formulation and process reproducibility are also critically evaluated, providing insights into current limitations and potential strategies for overcoming them. Finally, inkjet printing represents a transformative approach in pharmaceutical formulation development, offering scalability, flexibility, and the potential for on-demand manufacturing of patient-specific therapies. As research continues to refine inkjet printing processes and overcome existing technical challenges, this technology is poised to significantly enhance drug delivery performance and accelerate the transition toward personalised medicine. This review underscores the critical role of inkjet printing in redefining pharmaceutical technology and highlights its promising future in advancing next-generation drug delivery systems.
Indexed as
Identifiers
41840190What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.